Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hepatitis: HELP
Jon E. Arnason
Based on 1 article published since 2009
(Why 1 article?)
||||
Expertise Level

  What is this?

Expertscape's algorithms degrade at low publication numbers. Thus, with only 1 published article on Hepatitis from 2009 through 2019, it is not possible for Expertscape to reliably rate Jon E. Arnason's expertise on this topic.

Work Locations
Details
Most likely:    Harvard University Boston   Contact    
2016
  • Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; · Department of Pathology, Brigham and Women's Hospital, Boston, MA; · Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA; CLL Research Consortium, Moores UCSD Cancer Center, La Jolla, CA; · Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; CLL Research Consortium, Moores UCSD Cancer Center, La Jolla, CA; · Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA; · Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA; and. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 27247136
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here is the title of the one article written by Jon E. Arnason in 2009-2019 about Hepatitis:

  • Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity. 2016
Show Full Article Record
Google Searches

Learn more about Jon E. Arnason using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University Boston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Harvard University Boston
2016
  • Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; · Department of Pathology, Brigham and Women's Hospital, Boston, MA; · Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA; CLL Research Consortium, Moores UCSD Cancer Center, La Jolla, CA; · Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; CLL Research Consortium, Moores UCSD Cancer Center, La Jolla, CA; · Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA; · Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA; and. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 27247136
Yearly article counts 00010000000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.